CGA and neoplasm: The greatest limitation of our study is its single-center retrospective cohort nature, which resulted in the restricted availability of clinical data on patients’ symptoms (abdominal pain, jaundice, weight loss, etc.), and tumor marker findings (CEA, CA19-9, CgA).